These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. El Shabrawi-Caelen L; Kerl H; Cerroni L Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366 [TBL] [Abstract][Full Text] [Related]
6. Expression of complement regulator proteins in primary and metastatic malignant melanoma. Weichenthal M; Siemann U; Neuber K; Breitbart EW J Cutan Pathol; 1999 May; 26(5):217-21. PubMed ID: 10408345 [TBL] [Abstract][Full Text] [Related]
7. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes. Blochin E; Nonaka D Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373 [No Abstract] [Full Text] [Related]
9. Pathology of the sentinel lymph node in melanoma. Starz H Semin Oncol; 2004 Jun; 31(3):357-62. PubMed ID: 15190493 [TBL] [Abstract][Full Text] [Related]
10. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306 [TBL] [Abstract][Full Text] [Related]
11. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience. Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712 [TBL] [Abstract][Full Text] [Related]
12. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells. Mehregan DR; Hamzavi I Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068 [TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma-like melanoma with Touton-like giant cells. Lee JS; Kossard S Am J Dermatopathol; 2007 Oct; 29(5):480-1. PubMed ID: 17890920 [No Abstract] [Full Text] [Related]
14. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma. Svec A; Wilkinson L; Bury Y; Martin VG Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157 [No Abstract] [Full Text] [Related]
15. Paraganglioma-like dermal melanocytic tumor: a case report with particular features. Cimpean AM; Ceauşu R; Raica M Int J Clin Exp Pathol; 2009 Nov; 3(2):222-5. PubMed ID: 20126591 [TBL] [Abstract][Full Text] [Related]
16. Idiosyncrasies of scalp melanoma. Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396 [TBL] [Abstract][Full Text] [Related]
17. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338 [TBL] [Abstract][Full Text] [Related]
18. Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision. Miura K; Harada H; Tsutsui Y Pathol Int; 1999 Mar; 49(3):247-52. PubMed ID: 10338082 [TBL] [Abstract][Full Text] [Related]